Skip to content

Drug interactions

Dacomitinib + Desipramine

Severity: Major

Dacomitinib and Desipramine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dacomitinib is a strong CYP2D6 inhibitor, and desipramine is cleared mainly via CYP2D6. Desipramine exposure can rise markedly, increasing the risk of anticholinergic effects, cardiac conduction abnormalities and arrhythmia.

What this interaction means in plain words

Dacomitinib and Desipramine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dacomitinib belongs to Oncology; Desipramine belongs to Central Nervous System.

Evidence level: High

Why it happens

Dacomitinib inhibits CYP2D6, reducing the metabolism of desipramine.

What to do

Avoid the combination if possible. If used, reduce the desipramine dose guided by plasma levels and ECG monitoring, and watch for toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dacomitinib and Desipramine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dacomitinib with Desipramine?

MediHelp rates the interaction as major. Dacomitinib and Desipramine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dacomitinib is a strong CYP2D6 inhibitor, and desipramine is cleared mainly via CYP2D6. Desipramine exposure can rise markedly, increasing the risk of anticholinergic effects, cardiac conduction abnormalities and arrhythmia.

How serious is the interaction between Dacomitinib and Desipramine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If used, reduce the desipramine dose guided by plasma levels and ECG monitoring, and watch for toxicity.

What other medicines interact with Desipramine?

MediHelp also lists interactions of Desipramine with, for example, Disopyramide, Dofetilide, Ibutilide. The full list is on the Desipramine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in